bpc-157 injection subcutaneous or intramuscular vs Platelet-rich plasma for jumper's knee: a comprehensive review of efficacy, protocols, and future directions BPC-157: The Body Protection Compound
Description
Find your glow
Interventions The IM arm received 1 mg VB12 on alternate days in weeks 12, 1 mg/week in weeks 38 and 1 mg/month in weeks 952
Practical Demonstrations
ISO-tested by Vanguard Laboratory
Main outcome measures The primary outcome was the clinical pregnancy rate (CPR)
Same 0.9% benzyl alcohol preservation
